Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve As per the captioned subject, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gian Life Care Ltd has informed BSE that its Board of Directors will meet on Wednesday, 21st February 2026 at Kanpur. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September 2025 (Q2 FY26) and the quarter ended 31st December 2025 (Q3 FY26). The company has also confirmed that the trading window for insiders (Directors, KMPs, designated employees, and connected persons) has been closed since 1st October 2025 and will remain closed until 48 hours after the results are made public. This is a standard regulatory intimation under SEBI LODR Regulation 29(1)(a).
No immediate impact on shareholders — this is a routine pre-results announcement. Investors should watch for the actual unaudited numbers when released post 21st February 2026, as Q2 and Q3 FY26 results will be a combined update covering six months of performance.